AT302302B - Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten - Google Patents

Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten

Info

Publication number
AT302302B
AT302302B AT96771A AT96771A AT302302B AT 302302 B AT302302 B AT 302302B AT 96771 A AT96771 A AT 96771A AT 96771 A AT96771 A AT 96771A AT 302302 B AT302302 B AT 302302B
Authority
AT
Austria
Prior art keywords
preparation
new
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
AT96771A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT302302B publication Critical patent/AT302302B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT96771A 1970-02-05 1971-02-05 Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten AT302302B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2005116A DE2005116C3 (de) 1970-02-05 1970-02-05 Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester

Publications (1)

Publication Number Publication Date
AT302302B true AT302302B (de) 1972-10-10

Family

ID=5761434

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96771A AT302302B (de) 1970-02-05 1971-02-05 Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten

Country Status (17)

Country Link
US (1) US4048171A (de)
JP (1) JPS5550021B1 (de)
AT (1) AT302302B (de)
BE (1) BE762580A (de)
CA (1) CA944768A (de)
CH (1) CH553780A (de)
CS (1) CS161771B2 (de)
DE (1) DE2005116C3 (de)
DK (1) DK135282C (de)
ES (1) ES387973A1 (de)
FR (1) FR2150555B1 (de)
GB (2) GB1328479A (de)
IE (1) IE34896B1 (de)
IL (1) IL36018A0 (de)
NL (1) NL171580C (de)
YU (1) YU18471A (de)
ZA (1) ZA71438B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
DE2349538C2 (de) * 1973-10-02 1982-08-26 Ordena trudovogo krasnogo znameni institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Arzneimittel zur Behandlung von Lebererkrankungen
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
DE2844130A1 (de) * 1977-10-14 1979-04-26 Labaz Neue dihydropyridine und deren verwendung
DE3021958A1 (de) * 1980-06-12 1981-12-24 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4683234A (en) * 1984-05-19 1987-07-28 Suntory Limited 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
DE3432563A1 (de) * 1984-09-05 1986-03-13 Bayer Ag, 5090 Leverkusen Neue pyridylethyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5202330A (en) * 1985-06-03 1993-04-13 E. R. Squibb & Sons, Inc. 2-thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters
DE3677319D1 (de) * 1985-10-22 1991-03-07 Sanwa Kagaku Kenkyusho Co Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
US4753946A (en) * 1987-04-08 1988-06-28 E. R. Squibb & Sons, Inc. Pyrimidinecarboxylic acid derivatives
EP0330470A3 (de) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. Gegen Tumorzellen verwendbare 1,4-Dihydropyridin-Derivate
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
ATE548351T1 (de) * 1996-01-29 2012-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Dihydropyridin-pyridin-, benzopyranon- und triazolochinazolin-derivate, deren herstellung und verwendung als adenosinrezeptor-antagonisten
WO1997037667A1 (en) 1996-04-10 1997-10-16 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
CA2336967C (en) 1998-07-10 2010-06-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor antagonists
ATE336492T1 (de) * 2000-01-14 2006-09-15 Us Gov Health & Human Serv Methonocarbacycloalkylanaloga von nucleosiden
WO2011068978A1 (en) 2009-12-02 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US3511847A (en) * 1967-02-07 1970-05-12 Smithkline Corp 2,6-di-lower alkyl - 1,4-dihydro - 4-(2-trifluoromethylphenyl) - 3,5 - pyridinedicarboxylic acid esters
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
US3455939A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(4-chloro-3-sulfamoylphenyl)-1,4-dihydropyridines
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate

Also Published As

Publication number Publication date
FR2150555A1 (de) 1973-04-13
DE2005116C3 (de) 1980-02-14
DK135282B (da) 1977-03-28
NL171580C (nl) 1983-04-18
ZA71438B (en) 1971-10-27
CA944768A (en) 1974-04-02
DK135282C (da) 1977-08-15
GB1328479A (en) 1973-08-30
GB1326491A (en) 1973-08-15
IE34896B1 (en) 1975-09-17
NL7101234A (de) 1971-08-09
BE762580A (fr) 1971-08-05
CH553780A (de) 1974-09-13
NL171580B (nl) 1982-11-16
DE2005116B2 (de) 1979-06-07
YU18471A (en) 1978-12-31
DE2005116A1 (de) 1971-09-02
ES387973A1 (es) 1974-01-16
CS161771B2 (de) 1975-06-10
US4048171A (en) 1977-09-13
IL36018A0 (en) 1971-03-24
JPS5550021B1 (de) 1980-12-16
FR2150555B1 (de) 1974-09-06
IE34896L (en) 1971-08-05

Similar Documents

Publication Publication Date Title
AT306720B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT302302B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT313268B (de) Verfahren zur Herstellung von neuen 5-Aroylpyrrolderivaten
AT275521B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT316552B (de) Verfahren zur Herstellung von neuen unsymmetrischen 1,4-Dihydropyridinen
AT303040B (de) Verfahren zur Herstellung von neuen Azidophenyl-1,4-dihydroppyridinen
AT319948B (de) Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen
AT301546B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT293389B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridin-Derivaten
AT301545B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinen
AT310953B (de) Verfahren zur Herstellung von neuen 8,9-Didehydro-10-alkoxyergolenderivaten
AT312606B (de) Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden
AT299968B (de) Verfahren zur Herstellung von neuen 5-Imino-1,2,4-triazin-Derivaten
AT296270B (de) Verfahren zur Herstellung von neuen Derivaten der 2,3-Dialkyl-4-phenyl-cyclohexencarbonsäure
AT314094B (de) Verfahren zur Herstellung von neuen N(6)-Aralkyl-adenosin-Derivaten
ATA843973A (de) Verfahren zur herstellung von neuen 2,10-dichlor12-methyl-12h-dibenzo- (d,g) (1,3) -dioxocinderivaten
AT310761B (de) Verfahren zur Herstellung von neuen Triazolobenzodiazepin-5N-oxyd-Derivaten
CH555332A (de) Verfahren zur herstellung von neuen 1,3,3-trisubstituierten 3-azolylpropinen.
AT281816B (de) Verfahren zur Herstellung von neuen 1,2-Benzixothiazol-Derivate
CH518941A (de) Verfahren zur Herstellung von neuen 3,5-Dioxopyrazolidinderivaten
AT303726B (de) Verfahren zur Herstellung von neuen Triazol-pyrimidinderivaten
AT300792B (de) Verfahren zur Herstellung von neuen modifizierten N,N'substituierten 2,4,5-Triketoimidazolidinen
AT306259B (de) Verfahren zur Herstellung von neuen 3-Oxo-11β,18-epoxy-17α-R-17β-hydroxyöstra-4,9-dienen
AT304771B (de) Verfahren zur Herstellung von neuen Pyranosiden von 3β-Hydroxy-4-chlor-carda-4,20(22)-dienoliden
AT314542B (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee